4.7 Article

Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients

期刊

NPJ PRECISION ONCOLOGY
卷 5, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41698-021-00205-z

关键词

-

类别

资金

  1. National Natural Science Foundation of China [81571664, 81871323, 81801665, 81702465, U1804172]
  2. National Natural Science Foundation of Guangdong Province [2018B030311024]
  3. Scientific Research General Project of Guangzhou Science Technology and Innovation Commission [201707010328]
  4. China Postdoctoral Science Foundation [2016M600145]
  5. Science and Technology Program of Henan Province [192102310123, 182102310113, 192102310050]
  6. Youth Innovation Fund of The First Affiliated Hospital of Zhengzhou University
  7. Key Research Projects of Henan Higher Education [18A320077]
  8. Key Program of Medical Science and Technique Foundation of Henan Province [SBGJ202002062]
  9. Joint Construction Program of Medical Science and Technique Foundation of Henan Province [LHGJ20190156]

向作者/读者索取更多资源

MRI-based radiomics can be used for noninvasively detecting molecular groups and predicting survival in gliomas, regardless of grades. The image fusion model achieved high accuracy in predicting IDH and TERT status, while the cT1WI-based radiomic signature alone performed well in predicting 1p/19q status. Predictive molecular groups showed comparable prognostic value to actual ones in predicting PFS and OS. Prognostic nomograms based on grades and predictive molecular groups yielded good predictive performance for PFS and OS.
Gliomas can be classified into five molecular groups based on the status of IDH mutation, 1p/19q codeletion, and TERT promoter mutation, whereas they need to be obtained by biopsy or surgery. Thus, we aimed to use MRI-based radiomics to noninvasively predict the molecular groups and assess their prognostic value. We retrospectively identified 357 patients with gliomas and extracted radiomic features from their preoperative MRI images. Single-layered radiomic signatures were generated using a single MR sequence using Bayesian-regularization neural networks. Image fusion models were built by combing the significant radiomic signatures. By separately predicting the molecular markers, the predictive molecular groups were obtained. Prognostic nomograms were developed based on the predictive molecular groups and clinicopathologic data to predict progression-free survival (PFS) and overall survival (OS). The results showed that the image fusion model incorporating radiomic signatures from contrast-enhanced T1-weighted imaging (cT1WI) and apparent diffusion coefficient (ADC) achieved an AUC of 0.884 and 0.669 for predicting IDH and TERT status, respectively. cT1WI-based radiomic signature alone yielded favorable performance in predicting 1p/19q status (AUC = 0.815). The predictive molecular groups were comparable to actual ones in predicting PFS (C-index: 0.709 vs. 0.722, P = 0.241) and OS (C-index: 0.703 vs. 0.751, P = 0.359). Subgroup analyses by grades showed similar findings. The prognostic nomograms based on grades and the predictive molecular groups yielded a C-index of 0.736 and 0.735 in predicting PFS and OS, respectively. Accordingly, MRI-based radiomics may be useful for noninvasively detecting molecular groups and predicting survival in gliomas regardless of grades.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据